Principal Financial Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $130K | Buy |
|
|||||
|
2023
Q3 | $110K | Sell |
|
|||||
|
2023
Q2 | $2.22M | Sell |
|
|||||
|
2023
Q1 | $2.38M | Sell |
|
|||||
|
2022
Q4 | $2.63M | Sell |
|
|||||
|
2022
Q3 | $3.58M | Sell |
|
|||||
|
2022
Q2 | $4.21M | Sell |
|
|||||
|
2022
Q1 | $4.53M | Sell |
|
|||||
|
2021
Q4 | $6.6M | Sell |
|
|||||
|
2021
Q3 | $7.64M | Sell |
|
|||||
|
2021
Q2 | $9.7M | Sell |
|
|||||
|
2021
Q1 | $6.78M | Buy |
|
|||||
|
2020
Q4 | $5.84M | Buy |
|
|||||
|
2020
Q3 | $3.81M | Sell |
|
|||||
|
2020
Q2 | $4.68M | Sell |
|
|||||
|
2020
Q1 | $4.28M | Sell |
|
|||||
|
2019
Q4 | $7.04M | Buy |
|
|||||
|
2019
Q3 | $5.58M | Sell |
|
|||||
|
2019
Q2 | $5.99M | Sell |
|
|||||
|
2019
Q1 | $7.93M | Sell |
|
|||||
|
2018
Q4 | $11.3M | Sell |
|
|||||
|
2018
Q3 | $10.1M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $3.83M | Buy |
|
|||||
|
2017
Q2 | $3.46M | Buy |
|
|||||
|
2017
Q1 | $2.97M | Sell |
|
|||||
|
2016
Q4 | $3.43M | Buy |
|
|||||
|
2016
Q3 | $3.41M | Buy |
|
|||||
|
2016
Q2 | $2.28M | Sell |
|
|||||
|
2016
Q1 | $1.74M | Hold |
|
|||||
|
2015
Q4 | $1.94M | Hold |
|
|||||
|
2015
Q3 | $2.35M | Buy |
|
|||||
|
2015
Q2 | $2.62M | Buy |
|
|||||
|
2015
Q1 | $1.88M | Buy |
|
|||||
|
2014
Q4 | $2.7M | Sell |
|
|||||
|
2014
Q3 | $2.04M | Sell |
|
|||||
|
2014
Q2 | $3.25M | Buy |
|
|||||
|
2014
Q1 | $3.08M | Sell |
|
|||||
|
2013
Q4 | $2.55M | Buy |
|
|||||
|
2013
Q3 | $1.27M | Buy |
|
|||||
|
2013
Q2 | $119K | Buy |
|